BioVaxys Technology Corp.

BioVaxys Technology Corp.verified

BVAXF

Price:

$0.0498

Market Cap:

$17.82M

BioVaxys Technology Corp., a clinical biotechnology company, develops antiviral and anticancer vaccine platforms. It develops BVX-0320, a monovalent SARS-CoV-2 vaccine; and BVX-0918A, a haptenized tumor cell vaccine for ovarian cancer, as well as CoviDTH, which screens for an immune system response in patients exposed to SARS-CoV-2. The company is also developing Papilocare for human papilloma virus (HPV)-dependent cervical lesions; BVX-0918C for cervical cancer; BVX-0204 HPV viral vaccine; and BVX-0121, a multivalent SARS-CoV-2 vaccine. BioVaxys Technology Corp. has a bioproduction agreement with WuXi Biologics Limited that produces SARS-CoV-2 s-proteins for BVX-0320 and CoviDTH; research c...[Read more]

Industry

Biotechnology

IPO Date

2018-12-28

Stock Exchange

PNK

Ticker

BVAXF

The Enterprise Value as of November 2024 (TTM) for BioVaxys Technology Corp. (BVAXF) is 17.41M

According to BioVaxys Technology Corp.’s latest financial reports and current stock price. The company's current Enterprise Value is 17.41M. This represents a change of 82.76% compared to the average of 9.53M of the last 4 quarters.

BioVaxys Technology Corp. (BVAXF) Historical Enterprise Value (quarterly & annually)

How has BVAXF Enterprise Value performed in the past?

The mean historical Enterprise Value of BioVaxys Technology Corp. over the last ten years is 10.51M. The current 17.41M Enterprise Value has changed 16.46% with respect to the historical average. Over the past ten years (40 quarters), BVAXF's Enterprise Value was at its highest in in the October 2021 quarter at 33.36M. The Enterprise Value was at its lowest in in the October 2018 quarter at 0.

Quarterly (TTM)
Annual

Average

10.51M

Median

6.05M

Minimum

-15649.00

Maximum

30.18M

BioVaxys Technology Corp. (BVAXF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of BioVaxys Technology Corp. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.58%

Maximum Annual Enterprise Value = 30.18M

Minimum Annual Increase = -3947.96%

Minimum Annual Enterprise Value = -15649.00

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20232.01M-90.07%
202220.23M-32.96%
202130.18M199.16%
202010.09M1.58%
2019602.17K-3947.96%

BioVaxys Technology Corp. (BVAXF) Average Enterprise Value

How has BVAXF Enterprise Value performed in the past?

The current Enterprise Value of BioVaxys Technology Corp. (BVAXF) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

17.47M

5-year avg

12.62M

10-year avg

10.51M

BioVaxys Technology Corp. (BVAXF) Enterprise Value vs. Peers

How is BVAXF’s Enterprise Value compared to its peers?

BioVaxys Technology Corp.’s Enterprise Value is greater than Biotron Limited (16.98M), greater than Bioasis Technologies Inc. (397.14K), less than Covalon Technologies Ltd. (93.17M), greater than Mosaic ImmunoEngineering Inc. (8.29M), greater than Ceapro Inc. (16.01M), less than Cellectis S.A. (115.55M), greater than Adial Pharmaceuticals, Inc. WT EXP 073123 (1.27M), less than Small Pharma Inc. (0), less than TRACON Pharmaceuticals, Inc. (34.51M), greater than Wesana Health Holdings Inc. (-6162490.00), greater than GH Research PLC (255.22K), less than Algernon Pharmaceuticals Inc. (392.97M), greater than AXIM Biotechnologies, Inc. (1.14M), greater than null (7.10M),

Build a custom stock screener for BioVaxys Technology Corp. (BVAXF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioVaxys Technology Corp. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BioVaxys Technology Corp. (BVAXF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BioVaxys Technology Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is BioVaxys Technology Corp.'s Enterprise Value?

What is the highest Enterprise Value for BioVaxys Technology Corp. (BVAXF)?

What is the 3-year average Enterprise Value for BioVaxys Technology Corp. (BVAXF)?

What is the 5-year average Enterprise Value for BioVaxys Technology Corp. (BVAXF)?

How does the current Enterprise Value for BioVaxys Technology Corp. (BVAXF) compare to its historical average?